Logo

Cancer Research UK Expands License for DNAStar's Sequencing Software

Jan 31, 2007
NEW YORK (GenomeWeb News) - DNAStar said yesterday that Cancer Research UK has expanded its site license for the company’s Lasergene sequence analysis software.
 
In November, CR-UK licensed Lasergene for use at its Lincoln’s Inn Field and Clare Hall laboratories.
  
The new three-year agreement allows the Cambridge Research Institute and the Paterson Institute for Cancer Research to use the software at their labs as well.
 
GATC Biotech is DNAStar’s distributor for European markets.
 
Financial terms of the agreement were not released.

Filed under

Informatics
Breaking News
The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.